Krystal Biotech, Inc.
KRYS
$346.17
-$1.92-0.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 119.22M | 116.36M | 107.11M | 97.80M | 96.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 119.22M | 116.36M | 107.11M | 97.80M | 96.04M |
| Cost of Revenue | 6.44M | 6.32M | 6.59M | 4.26M | 7.17M |
| Gross Profit | 112.79M | 110.03M | 100.51M | 93.54M | 88.88M |
| SG&A Expenses | 39.85M | 41.01M | 41.45M | 37.58M | 35.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.81M | 62.67M | 62.84M | 56.43M | 56.64M |
| Operating Income | 58.42M | 53.69M | 44.27M | 41.37M | 39.40M |
| Income Before Tax | 66.08M | 61.44M | 51.13M | 47.97M | 46.78M |
| Income Tax Expenses | 11.31M | 5.51M | -269.00K | -31.40M | 8.44M |
| Earnings from Continuing Operations | 54.77M | 55.93M | 51.40M | 79.37M | 38.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.77M | 55.93M | 51.40M | 79.37M | 38.33M |
| EBIT | 58.42M | 53.69M | 44.27M | 41.37M | 39.40M |
| EBITDA | 58.57M | 54.21M | 44.83M | 41.68M | 39.75M |
| EPS Basic | 1.85 | 1.91 | 1.77 | 2.74 | 1.33 |
| Normalized Basic EPS | 1.40 | 1.31 | 1.10 | 1.04 | 1.01 |
| EPS Diluted | 1.79 | 1.83 | 1.70 | 2.66 | 1.29 |
| Normalized Diluted EPS | 1.35 | 1.26 | 1.06 | 1.00 | 0.98 |
| Average Basic Shares Outstanding | 29.53M | 29.29M | 29.09M | 28.95M | 28.91M |
| Average Diluted Shares Outstanding | 30.66M | 30.51M | 30.25M | 29.83M | 29.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |